Hematologic Malignancies
News
First CAR T-cell therapy for multiple myeloma: Abecma
“The results of this trial represent a true turning point in the treatment of this disease.”
News
Concern over response to COVID-19 in patients with blood cancers
Case Reports
Sequential Targeted Treatment for a Geriatric Patient with Acute Myeloid Leukemia with Concurrent FLT3-TKD and IDH1 Mutations
Targeting and monitoring several acute myeloid leukemia mutations sequentially provides insights into optimal treatment plans.
News
Experts offer roadmap for treating CLL during the pandemic
Conference Coverage
Study found dual-targeted CAR T highly active against relapsed/refractory multiple myeloma
Conference Coverage
Synthetic lethality: Triple combination is a viable strategy for B-cell malignancies
Conference Coverage
Highly effective in Ph-negative B-cell ALL: Hyper-CVAD with sequential blinatumomab
News
Patients with lung and blood cancers most vulnerable to COVID-19
News
Extended virus shedding after COVID-19 in some patients with cancer
Some patients, including stem cell transplant and CAR T recipients, may require extended periods of isolation.
Conference Coverage
Fixed duration ibrutinib/venetoclax appears feasible for some CLL/SLL patients